Headline
The latest stories from AHA Today.
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to treat patients 12 and older with mild-to-moderate COVID-19 who are at high risk for progressing to severe disease but not hospitalized or on oxygen therapy.
To improve Americans’ access to care, stop the COVID-19 pandemic and advance health equity, AHA and seven other national organizations voiced support for six principles to make health coverage more available and affordable.
The Accountable Health Communities model reduced hospital emergency department visits by 9% for Medicare fee-for-service beneficiaries screened for health-related social needs, according to the first report evaluating the Centers for Medicare & Medicaid Services model.
An estimated 68% of U.S. adults intended to receive a COVID-19 vaccine when surveyed by the Centers for Disease Control and Prevention in December, up from 61.9% in September.
The Centers for Medicare & Medicaid Services extended from Feb. 8 to March 17 the deadline for inpatient prospective payment system hospitals and PPS-exempt cancer hospitals to submit third quarter 2020 Hospital Consumer Assessment of Healthcare Providers and Systems data.
The Food and Drug Administration issued updated guidance on using ventilator splitters to support more than one patient when other options are unavailable.
Leaders from WakeMed Health and Hospitals in Raleigh, N.C., share strategies to overcome behavioral health disparities and increase patients’ access to appropriate caregivers at the right time and place.
Lesbian, gay and bisexual persons in the U.S. have higher self-reported prevalence of several underlying health conditions associated with severe COVID-19 outcomes, compared to heterosexual persons, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration revised and reissued its emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19.
Each year, the AHA Dick Davidson NOVA Award program recognizes health care’s bright stars who are working to improve community health through collaborations with other stakeholders.